Zydus Lifesciences#39; arm has taken over the development and commercialization of CUTX-101, a product for treating Menkes disease
Zydus Life shares rise as US arm gains rights for rare paediatric disease drug on December 6, 2023 at 6:11 am
Zydus Lifesciences#39; arm has taken over the development and commercialization of CUTX-101, a product for treating Menkes disease